Share Prices & Company Research

Market News

23 May 2019 | 09:17

Alliance Pharma continues to trade 'well' amid boost from International Star, local brands

Alliance Pharma it continued to trade 'well,' amid continued growth from its International Star brands and a 'solid' performance from its local brands. The company also confirmed that it had not benefit from any price increases in prochlorperazine amid an ongoing probe by UK authorities into the sale of the prescription drug. 'Consequently we continue to generate strong free cash flow and, in the absence of further acquisitions, expect our adjusted net debt/EBITDA leverage ratio to reduce below 2.0 times during the second half of the year,' the company said. In a separate statement, Alliance confirmed that it had not been involved in the pricing or distribution of prochlorperazine since 2013 and that it had not benefited from any price increases. This comes in the wake of the release of provisional findings following an investigation by the Competition and Markets Authority into the sale of prescription prochlorperazine. 'We will work closely with the CMA to resolve its provisional findings,' Alliance added.

At 9:17am: (LON:APH) Alliance Pharma PLC share price was -0.8p at 77.8p

Story provided by StockMarketWire.com
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.